SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: StockMiser who wrote (2229)2/9/2000 11:38:00 PM
From: Carl R.  Read Replies (1) of 5582
 
One comment on your point concerning the ease of copying the product without infringing on the patent. I do agree that it should be possible to get around the patent, but my understanding is that a simple saline solution is not adequate. From my reading of the thread my understanding is that the gel is in fact what makes the product work. The problem, as I understand it, is that the normal nasal discharge is sufficient to wash away the Zinc under normal circumstances, and sneezing is also a problem. The gel was devised so as to be hold the zinc in place giving it time to be absorbed and do its work.

I do agree that if others want into this market badly enough they may well be able to devise other methods of holding the zinc in place, but I do think that the patent probably provides some protection. On the other hand, if the market is so good that others want in, I would expect the stock to be significantly higher than this before competition can get in.

Carl
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News